¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phospholipid profile"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phospholipid
    ÀÎÁöÁú
  • antigenic profile
    Ç׿øÇÁ·ÎÇÊ
  • beam profile
    ºöÃø¸éµµ, ¼ÓÃø¸é»ó, À½¼ÓÃø¸é»ó
  • biophysical profile
    »ý¹°¸®Çаè¼ö
  • complement profile
    º¸Ã¼Ãø¸é»ó
  • dose profile
    ¹æ»ç¼±·®Ãø¸éµµ
  • flow velocity profile
    È帧¼ÓµµºÐÆ÷»ó, À¯¼ÓºÐÆ÷»ó
  • profile
    1. Ãø¸é»ó 2. °è¼ö
  • slice profile
    ÀýÆíÃø¸éµµ
  • urethral pressure profile
    ¿äµµ³»¾Ð°î¼±
  • velocity profile
    ¼ÓµµºÐÆ÷»ó, ¼ÓµµºÐÆ÷Çü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phospholipid
    ÀÎÁöÁú
  • profile
    1. Ãø¸é»ó, 2. °è¼ö
  • biophysical profile
    »ý¹°¸®Çаè¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phospholipid
    ÀÎÁöÁú
  • antigenic profile
    Ç׿øÇÁ·ÎÇÊ
  • beam profile
    ºöÃø¸éµµ, ¼ÓÃø¸é»ó, À½¼ÓÃø¸é»ó
  • complement profile
    µµ¿òÃ¼Ãø¸é»ó
  • dose profile
    ¹æ»ç¼±·®Ãø¸éµµ
  • flow velocity profile
    È帧¼ÓµµºÐÆ÷»ó, À¯¼ÓºÐÆ÷»ó
  • profile
    Ãø¸é»ó
  • slice profile
    ÀýÆíÃø¸éµµ
  • urethral pressure profile
    ¿äµµ³»¾Ð°î¼±
  • velocity profile
    ¼ÓµµºÐÆ÷»ó, ¼ÓµµºÐÆ÷Çü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phospholipid profile
    ÀÎÁöÁúÇÁ·ÎÇÊ<¾ç»ó(åÆßÓ)>
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phospholipid
    ÀÎÁöÁú(ìÝò·òõ).
  • phospholipid
    ÀÎÁöÁú(×òò·òõ)
  • phospholipid
    ÀÎÁöÁú
  • antigenic profile
    Ç׿ø(ù÷ê«)ÇÁ·ÎÇÊ.
  • functional profile length
    ±â´ÉÀû(¿äµµ)Ãø¸é?±æÀÌ
  • personality profile
    ÀÎ°Ý ÇÁ·ÎÇÊ
  • profile plasty
    Ãø¸é¼ºÇü¼ú
  • profile to X-ray beam
    Á¾´Ü¸é, ¿·¸é
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phospholipid profile
    ÀÎÁöÁúÇÁ·ÎÇÊ<¾ç»ó(åÆßÓ)>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phospholipid
    ÀÎÁöÁú
  • phospholipid
    ÀÎÁöÁú(ìÝò·òõ).
  • phospholipid
    ÀÎÁöÁú(×òò·òõ)
  • antigenic profile
    Ç׿ø(ù÷ê«)ÇÁ·ÎÇÊ.
  • assumed velocity profile
    °¡»ó ¼Óµµ ºÐÆ÷»óÅÂ
  • beam profile
    ºöÃø¸éµµ
  • beam profile
    À½¼Ó Ãø¸é»ó (ëåáÖ ö°ØüßÀ)
  • beam profile
    ¼Ó Ãø¸é»ó
  • complement profile
    º¸Ã¼Ãø¸é»ó(ö°ØüßÀ)
  • dose profile
    ¼±·®Ãø¸éµµ
  • flow velocity profile
    À¯¼Ó ºÐÆ÷»ó
  • functional profile length
    ±â´ÉÀû(¿äµµ)Ãø¸é?±æÀÌ
  • personality profile
    ÀÎ°Ý ÇÁ·ÎÇÊ
  • profile plasty
    Ãø¸é¼ºÇü¼ú
  • profile to X-ray beam
    Á¾´Ü¸é, ¿·¸é
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • active phospholipid
    Ȱ¼ºÀÎÁöÁú (üÀàõ×òò·òõ)
  • inositol phospholipid
    À̳ë½ÃÅç ÀÎÁöÁú(×òò·òõ)
  • phospholipid
    ÀλêÁöÁú(×òß«ò·òõ)
  • phospholipid effect
    ÀλêÁöÁúÈ¿°ú(×òß«ò·òõüùÍý)
  • elution profile
    ¿ë¸®(éÁ×î) ÇÁ·ÎÇÊ
  • induction profile
    À¯µµ¾ç»ó(ë¯ÓôåÆßÓ)
  • melting profile
    À¶ÇØ(ë×ú°)ÇÁ·ÎÇÊ
  • polysome profile
    Æú¸®¼Ø ÇÁ·ÎÇÊ
  • profile
    ÇÁ·ÎÇÊ
  • thermal denaturation profile
    ¿­º¯¼º(æðܨàõ) ÇÁ·ÎÇÊ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • phospholipid
    ÀÎÁöÁú
  • assumed velocity profile
    °¡»ó¼ÓµµºÐÆ÷»óÅÂ
  • beam profile
    ¼ÓÃø¸é»ó
  • field profile
    ÀÚÀåÃø¸é»ó
  • flow velocity profile
    À¯¼ÓºÐÆ÷»ó
  • profile
    ¿·¸ð½À, Ãø¸é»ó, Ãø¸ð
  • profile to X-ray beam
    Á¾´Ü¸é, ¿·¸é
  • section sensitivity profile(SSP)
    ÀýÆí¹Î°¨Ãø¸é
  • slice profile
    ÀýÆíÃø¸éµµ
  • velocity profile
    ¼ÓµµºÐÆ÷»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MCPP metacarpophalangeal pattern profile; metacarpophalangeal profile; meta-chlorophenylpiperazine
PL PLatelet phospholipid
BPC Behavior Problem Checklist; bile phospholipid concentration; blood pressure cuff; British Pharmaceut...
C/P cholesterol-phospholipid [ratio]
C/PL cholesterol/phospholipid [ratio]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BPP Bio-Physical Profile
HPLP Health Promoting Lifestyle Profile
LSP Life Skill Profile
MCPP Metacarpophalangeal pattern profile
NHP Nottingham Health Profile
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • phospholipid
    ÀÎ ÁöÁú
    ÀÎÀ» ÇÔÀ¯ÇÏ´Â ÁöÁú·Î¼­ °¡¼öºÐÇØ¿¡ ÀÇÇÏ¿© Áö¹æ»ê, ±Û¸®¼¼¸° ¹× Áú¼Ò È­ÇÕ¹°À» »ý¼ºÇÑ´Ù. ·¹½Ãƾ, ¼¼ÆÈ¸° ¹× ½ºÇÎ°í ¹Ì¿¤¸° µîÀÌ Àß ¾Ë·ÁÁø °ÍµéÀÌ´Ù.
  • serum phospholipid
    Ç÷û ÀÎÁöÁú
    Ç÷û ÀÎÁöÁúÀÇ Á¤»óÄ¡´Â 180-220§·/§£À̰í, Ç÷û ÄÝ·¹½ºÅ×·ÑÀÇ ±×°Í°ú °ÅÀÇ À¯»çÇÏ´Ù.
  • assumed velocity profile
    °¡»ó ¼Óµµ ºÐÆ÷ »óÅÂ
  • dose profile
    ¼±·® Ãø¸éµµ
  • emergence profile
    ÃâÇö Ãø¸ð, ÃâÇö À±°û
  • field profile
    ÀÚÀå Ãø¸é »ó
  • heating and cooling temperature-place-time profile
    °¡¿­ ¹× ³Ã°¢ ¿Âµµ-À§Ä¡-½Ã°£ Çü
  • profile facial
    ¾È¸é Ãø¸éµµ
  • profile test
    ÇÁ·ÎÆÄÀÏ °Ë»ç
  • slice profile
    ÀýÆí Ãø¸éµµ
  • straight- jawed profile
    Á¤À§¾Ç ¿· ¸ð½À
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acyl-(acyl-carrier-protein)-phospholipid acyltransferase <enzyme> Catalyses the formation of phosphatidylethanolamine from acyl-acyl carrier protein and 2-acyl-sn-glycero-3-phosphoethanolamine
Registry number: EC 2.3.1.40
Synonym: 2-acyl-gpe acyltransferase, 2-acylglycerophosphoethanolamine acyltransferase
(26 Jun 1999)
phospholipid <biochemistry> The major structural lipid of most cellular membranes (except the chloroplast which has galactolipids). Contain phosphate, usually as a diester.
Examples include phosphatidyl phospholipids, plasmalogens and sphingomyelins.
(18 Nov 1997)
phospholipid bilayer <biochemistry> A lamellar organisation of phospholipids that are packed as a bilayer with hydrophobic acyl tails inwardly directed and polar head groups on the outside surfaces.
It is this bilayer that forms the basis of membranes in cells, though in most cellular membranes a very substantial proportion of the area may be occupied by integral proteins. The triple layered appearance of membranes seen in electron microscopy is thought to arise because the osmium tetroxide binds to the polar regions leaving a central, unstained, hydrophobic region.
(31 Dec 1997)
phospholipid ethers Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues.
(12 Dec 1998)
phospholipid-hydroperoxide glutathione peroxidase <enzyme> Selenoenzyme found in biological materials; different from glutathione peroxidase EC 1.11.1.9
Registry number: EC 1.11.1.-
Synonym: pH-gperoxidase
(26 Jun 1999)
phospholipid syndrome <syndrome> The combination of antiphospholipid antibodies and the presence of either arterial or venous occlusive events such as thrombosis.
(05 Mar 2000)
phospholipid transfer protein <protein> Cytoplasmic proteins that bind phospholipids and facilitate their transfer between cellular membranes. May also cause net transfer from the site of synthesis.
(18 Nov 1997)
biochemical profile A combination of biochemical tests usually performed with automated instrumentation upon admission of a patient to a hospital or clinic.
(05 Mar 2000)
biophysical profile <radiology> Parameters (30 minute observation period): reactive NST, foetal breathing movement: breathing period at least 60 seconds, foetal body movement, greater than 3 discrete movements of limbs/trunk, foetal tone: upper and lower limbs usually flexed with head on chest, greater than 1 episode of extension with return to flexion, amniotic fluid volume: largest pocket greater than 1 cm in vertical diameter without containing loops of cord score: 2 points if normal; 0 points for abnormal results: 8-10 = maximal score, 0-4 = severe foetal compromise; delivery indicated, 33% sensitivity; 17% positive predictive value
(12 Dec 1998)
personality profile A method by which the results of psychological testing are presented in graphic form, a vignette or brief personality description.
(05 Mar 2000)
coagulation profile A test which measures the speed of blood coagulation at different steps of the coagulation pathway.
(27 Sep 1997)
profile Vertical section of the soil through all its horizons and extending into the parent material.
(09 Oct 1997)
profile record A registration or record of the profile of a patient.
(05 Mar 2000)
sickness impact profile A quality-of-life scale developed in the united states in 1972 as a measure of health status or dysfunction generated by a disease. It is a behaviourally based questionnaire for patients and addresses activities such as sleep and rest, mobility, recreation, home management, emotional behaviour, social interaction, and the like. It measures the patient's perceived health status and is sensitive enough to detect changes or differences in health status occurring over time or between groups.
(12 Dec 1998)
soil profile A vertical section of the soil through all its horizons and extending into the parent material.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • profile
    ¿·¸ð½À
  • high profile
    ¸íÈ®ÇÑ Åµµ(Á¤Ã¥);¼±¸íÇÑ ÀÔÀå
  • profile
    ¾ó±¼;Ãø¸é;À±°û;Àι°´ÜÆò;Ãø¸éµµ;...ÀÇ À±°ûÀ»(Ãø¸éµµ¸¦)±×¸®´Ù;Àι°ÆòÀ»¾²´Ù
  • profile drag
    (³¯°³ÀÇ)´Ü¸é ÀúÇ×
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á